Home / Business and Economy / Piramal Pharma Solutions Achieves 70+ Regulatory Approvals
Piramal Pharma Solutions Achieves 70+ Regulatory Approvals
22 Jun
Summary
- Piramal completed over 200 customer audits in the past fiscal year.
- Over 70 regulatory agency approvals were received globally by Piramal.
- Digital tools like eLab and iAssist enhance Piramal's quality processes.
Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization, announced a successful past fiscal year, marked by over 200 customer audits and more than 70 regulatory agency approvals across its network. This performance highlights the strength of its comprehensive quality strategy.
The company's quality approach combines robust governance, a strong quality culture, workforce development, process harmonization, and digital transformation. This integrated strategy ensures sustained compliance, continuous audit readiness, and operational effectiveness.
Key initiatives like the RESOLVE program focus on right-first-time execution in manufacturing and QC labs. Specialized training programs enhance audit readiness and regulatory engagement, further solidifying quality capabilities.
Digital platforms, including eLab for QC lab digitization and exForms for GxP form digitalization, are improving efficiency and transparency. The adoption of iAssist, an AI-enabled tool, supports the speed and rigor of investigations, complementing existing digitized QMS, LMS, and DMS platforms.
